[Wuding] February 2026 Monthly Revenue NT$178 Million (YoY -12.0%)
Wuding (1733) announced its February 2026 monthly revenue was NT$178 million, a 12.0% decrease compared to the same period last year. As a leading biotech and medical industry player specializing in blood glucose monitoring systems, its revenue performance is related to changes in demand in the global diabetes care market.
📋 Article Processing Timeline
- 📰 Published: February 1, 2026 at 09:00
- 🔍 Collected: April 7, 2026 at 08:00 (1559h 0m after Published)
- 🤖 AI Analyzed: April 8, 2026 at 00:18 (16h 18m after Collected)
Company Code: 1733
Company Name: Wuding
Industry: Biotechnology and Medical Industry
Data Month/Year: 2026-02
Current Month Revenue: NT$178,279 Thousand (NT$178 Million)
Year-over-year Change from Same Month Last Year: -12.0%
Company Name: Wuding
Industry: Biotechnology and Medical Industry
Data Month/Year: 2026-02
Current Month Revenue: NT$178,279 Thousand (NT$178 Million)
Year-over-year Change from Same Month Last Year: -12.0%